U.S. markets open in 1 hour 29 minutes

Dr. Reddy's Laboratories Limited (RDY)

NYSE - NYSE Delayed Price. Currency in USD
69.43-0.33 (-0.47%)
At close: 04:00PM EST
69.00 -0.43 (-0.62%)
Pre-Market: 07:35AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close69.76
Bid68.83 x 800
Ask70.52 x 800
Day's Range69.03 - 69.74
52 Week Range51.11 - 73.17
Avg. Volume254,552
Market Cap11.56B
Beta (5Y Monthly)0.37
PE Ratio (TTM)18.92
EPS (TTM)3.67
Earnings DateN/A
Forward Dividend & Yield0.49 (0.70%)
Ex-Dividend DateJul 07, 2023
1y Target Est70.61
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RDY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Dr. Reddy's Laboratories Ltd
    Analyst Report: Dr. Reddy's Laboratories LimitedDr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.